Also known as: DB289; Prasugrel hydrochloride
Prasugrel is a thienopyridine antiplatelet agent that irreversibly inhibits the P2Y12 receptor on platelets, thereby preventing ADP-mediated platelet aggregation. It is used to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI). Mediocon Inc manufactures Prasugrel API at its GMP-certified facility in Aurangabad, Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 150322-43-3 |
| Molecular Formula | C20H24NO4S |
| Molecular Weight | 456.51 g/mol |
| Grade | IP / BP / USP |
| Category | Antiplatelet Agent |
| Appearance | White to off-white, crystalline powder |
| Solubility | Freely soluble in methanol, soluble in ethanol and slightly soluble in water |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PRAS/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Prasugrel — CAS 150322-43-3 (CAS 150322-43-3) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Prasugrel — CAS 150322-43-3 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance